세계의 바이오 임플란트 시장 규모, 점유율, 동향 분석 : 최종사용자별, 유형별, 지역별, 전망 및 예측(2024-2031년)

Global Bioimplants Market Size, Share & Trends Analysis Report By End User, By Type, By Regional Outlook and Forecast, 2024 - 2031

US $ 3,600 ￦ 4,988,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 5,986,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,381,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

바이오 임플란트 시장 규모는 예측 기간 동안 8.0%의 CAGR로 성장하여 2031년까지 2,392억 달러에 달할 것으로 예상됩니다.

그러나 연구개발에 필요한 막대한 투자로 인해 경제적 부담이 시작됩니다. 이러한 임플란트의 제조 공정도 높은 가격의 원인 중 하나입니다. 이러한 첨단 의료기기의 제조에는 일반적으로 고급 및 고가의 재료가 사용됩니다. 따라서 개발, 제조 및 구현과 관련된 높은 비용은 광범위한 도입에 큰 장벽이 되고 있습니다.

또 한 가지 주목할 만한 긍정적인 영향 중 하나는 원격의료와 디지털 건강 기술의 도입이 가속화되었다는 점입니다. 이러한 변화는 임플란트가 필요한 환자를 포함하여 만성 질환을 앓고 있는 환자를 지속적으로 모니터링하고 추적 관찰할 수 있게 해줍니다. 대면 진료가 제한됨에 따라 의료 서비스 제공자는 환자 치료를 유지하기 위해 원격의료 플랫폼에 점점 더 의존하고 있습니다. 따라서 전염병은 전반적으로 시장에 부정적인 영향을 미쳤습니다.

최종사용자 전망

최종사용자를 기준으로 시장은 병원, 전문 클리닉, 외래 수술 센터로 분류됩니다. 전문 클리닉 부문은 2023년 시장에서 32%의 매출 점유율을 기록했습니다. 전문 클리닉은 심장학, 정형외과, 치과, 안과 등 특정 의료 분야를 전문으로하며 특정 건강 상태를 가진 환자에게 고도로 전문적인 치료를 제공합니다.

유형별 전망

유형에 따라 시장은 치과용 바이오 임플란트, 정형외과용 바이오 임플란트, 척추 바이오 임플란트, 안과용 바이오 임플란트, 심혈관 바이오 임플란트, 기타로 분류됩니다. 심혈관 바이오 임플란트 부문은 2023년 시장에서 20%의 매출 점유율을 차지했습니다. 심혈관 질환(CVD)은 전 세계적으로 이환율과 사망률의 가장 흔한 원인 중 하나이기 때문에 효과적이고 신뢰할 수 있는 치료 옵션이 필요합니다.

지역 전망

지역별로 보면 시장은 북미, 유럽, 아시아태평양, LAMEA에 걸쳐 분석되었습니다. 북미 부문은 2023년 시장에서 36%의 매출 점유율을 차지했습니다. 이러한 리더십은 주로 이 지역의 첨단 의료 인프라, 높은 의료 비용, 저명한 바이오 임플란트 제조업체의 존재에 기인합니다. 특히 미국은 강력한 의료 연구 생태계, 첨단 의료 기술의 광범위한 채택, 유리한 상환 정책으로 인해 시장의 주요 플레이어입니다.

목차

제1장 시장 범위와 조사 방법

• 시장 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요람

• 주요 하이라이트

제3장 시장 개요

• 소개
  • 개요
    • 시장 구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 과제
• Porter's Five Forces 분석

제4장 바이오 임플란트 세계 시장 : 최종사용자별

• 세계의 병원 시장 : 지역별
• 세계의 전문 클리닉 시장 : 지역별
• 세계의 외래 수술 센터 시장 : 지역별

제5장 바이오 임플란트 세계 시장 : 유형별

• 세계의 정형외과용 바이오 임플란트 시장 : 지역별
• 세계의 심혈관 바이오 임플란트 시장 : 지역별
• 세계의 척추 바이오 임플란트 시장 : 지역별
• 세계의 치과용 바이오 임플란트 시장 : 지역별
• 세계의 안과용 바이오 임플란트 시장 : 지역별
• 세계의 기타 시장 : 지역별

제6장 바이오 임플란트 세계 시장 : 지역별

• 북미
  • 북미의 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽의 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양의 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카, 중동 및 아프리카
  • 라틴아메리카, 중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트
    • 사우디아라비아
    • 남아프리카공화국
    • 나이지리아
    • 기타 라틴아메리카, 중동 및 아프리카

제7장 기업 개요

• Stryker Corporation
• Arthrex, Inc
• Zimmer Biomet Holdings, Inc
• Medtronic PLC
• Smith & Nephew PLC
• Dentsply Sirona, Inc
• Johnson & Johnson
• Boston Scientific Corporation
• Abbott Laboratories
• Victrex plc

제8장 바이오 임플란트 시장 성공 필수 조건

ksm

영문 목차

영문목차

The Global Bioimplants Market size is expected to reach $239.2 billion by 2031, rising at a market growth of 8.0% CAGR during the forecast period.

Europe is known for its comprehensive healthcare systems, high standards of medical care, and strong emphasis on medical research and innovation. Countries like Germany, France, the United Kingdom, and Italy are key contributors to the market in Europe, driven by their advanced healthcare facilities and growing geriatric population. Consequently, the European region would acquire nearly 30% of the total market share by 2031.

Innovations in biotechnology, materials science, and medical engineering have led to the development of more effective, durable, and biocompatible implants, which have been instrumental in boosting their adoption. Materials science has been equally instrumental in developing new and improved bioimplant materials. Hence, these developments will aid in the growth of the market. Additionally, Worldwide, the prevalence of chronic conditions, including cardiovascular diseases, orthopedic disorders, and dental issues, has resulted in the necessity of these implants for the effective treatment and management of these conditions. Dental problems are another significant contributor to the increasing demand for these implants. Millions of individuals worldwide are affected by tooth loss, periodontal disease, and other dental conditions, necessitating the development of effective restorative solutions. Thus, the increasing prevalence of chronic diseases such as cardiovascular diseases, orthopedic disorders, and dental problems is a key factor driving the demand for these implants.

However, the financial burden begins with the substantial investment required for research and development. The manufacturing processes for these implants further contribute to their high price. Producing these advanced medical devices typically involves using sophisticated and expensive materials. Hence, the high costs associated with their development, production, and implementation remain a significant barrier to widespread adoption.

Moreover, one of the notable positive impacts was the accelerated adoption of telemedicine and digital health technologies. This shift enabled continuous monitoring and follow-up for patients with chronic conditions, including those requiring these implants. With restrictions on in-person consultations, healthcare providers increasingly turned to telehealth platforms to maintain patient care. Thus, the pandemic had an overall negative impact on the market.

End User Outlook

On the basis of end user, the market is classified into hospitals, speciality clinics, and ambulatory surgical centers. The specialty clinics segment witnessed 32% revenue share in the market in 2023. Specialist clinics concentrate on particular medical disciplines, including cardiology, orthopedics, dentistry, and ophthalmology, providing patients with particular medical conditions with highly specialized care.

Type Outlook

Based on type, the market is divided into dental bioimplants, orthopedic bioimplants, spinal bioimplants, ophthalmology bioimplants, cardiovascular bioimplants, and others. The cardiovascular bioimplants segment procured 20% revenue share in the market in 2023. Effective and dependable treatment options are required due to the fact that cardiovascular diseases (CVDs) continue to be one of the most prevalent causes of morbidity and mortality on a global scale.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 36% revenue share in the market in 2023. This leadership is primarily due to the region's sophisticated healthcare infrastructure, high healthcare expenditure, and the presence of prominent bioimplant manufacturers. The United States, in particular, is a key player in the market, as it has a robust medical research ecosystem, extensive adoption of sophisticated medical technologies, and favorable reimbursement policies.

List of Key Companies Profiled

• Stryker Corporation
• Arthrex, Inc.
• Zimmer Biomet Holdings, Inc.
• Medtronic PLC
• Smith & Nephew PLC
• Dentsply Sirona Inc.
• Johnson & Johnson
• Boston Scientific Corporation
• Abbott Laboratories
• Victrex plc

Global Bioimplants Market Report Segmentation

By End User

• Hospitals
• Speciality Clinics
• Ambulatory Surgical Centers

By Type

• Orthopedic Bioimplants
• Cardiovascular Bioimplants
• Spinal Bioimplants
• Dental Bioimplants
• Ophthalmology Bioimplants
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Bioimplants Market, by End User
  • 1.4.2 Global Bioimplants Market, by Type
  • 1.4.3 Global Bioimplants Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Bioimplants Market by End User

• 4.1 Global Hospitals Market by Region
• 4.2 Global Speciality Clinics Market by Region
• 4.3 Global Ambulatory Surgical Centers Market by Region

Chapter 5. Global Bioimplants Market by Type

• 5.1 Global Orthopedic Bioimplants Market by Region
• 5.2 Global Cardiovascular Bioimplants Market by Region
• 5.3 Global Spinal Bioimplants Market by Region
• 5.4 Global Dental Bioimplants Market by Region
• 5.5 Global Ophthalmology Bioimplants Market by Region
• 5.6 Global Others Market by Region

Chapter 6. Global Bioimplants Market by Region

• 6.1 North America Bioimplants Market
  • 6.1.1 North America Bioimplants Market by End User
    • 6.1.1.1 North America Hospitals Market by Country
    • 6.1.1.2 North America Speciality Clinics Market by Country
    • 6.1.1.3 North America Ambulatory Surgical Centers Market by Country
  • 6.1.2 North America Bioimplants Market by Type
    • 6.1.2.1 North America Orthopedic Bioimplants Market by Country
    • 6.1.2.2 North America Cardiovascular Bioimplants Market by Country
    • 6.1.2.3 North America Spinal Bioimplants Market by Country
    • 6.1.2.4 North America Dental Bioimplants Market by Country
    • 6.1.2.5 North America Ophthalmology Bioimplants Market by Country
    • 6.1.2.6 North America Others Market by Country
  • 6.1.3 North America Bioimplants Market by Country
    • 6.1.3.1 US Bioimplants Market
      • 6.1.3.1.1 US Bioimplants Market by End User
      • 6.1.3.1.2 US Bioimplants Market by Type
    • 6.1.3.2 Canada Bioimplants Market
      • 6.1.3.2.1 Canada Bioimplants Market by End User
      • 6.1.3.2.2 Canada Bioimplants Market by Type
    • 6.1.3.3 Mexico Bioimplants Market
      • 6.1.3.3.1 Mexico Bioimplants Market by End User
      • 6.1.3.3.2 Mexico Bioimplants Market by Type
    • 6.1.3.4 Rest of North America Bioimplants Market
      • 6.1.3.4.1 Rest of North America Bioimplants Market by End User
      • 6.1.3.4.2 Rest of North America Bioimplants Market by Type
• 6.2 Europe Bioimplants Market
  • 6.2.1 Europe Bioimplants Market by End User
    • 6.2.1.1 Europe Hospitals Market by Country
    • 6.2.1.2 Europe Speciality Clinics Market by Country
    • 6.2.1.3 Europe Ambulatory Surgical Centers Market by Country
  • 6.2.2 Europe Bioimplants Market by Type
    • 6.2.2.1 Europe Orthopedic Bioimplants Market by Country
    • 6.2.2.2 Europe Cardiovascular Bioimplants Market by Country
    • 6.2.2.3 Europe Spinal Bioimplants Market by Country
    • 6.2.2.4 Europe Dental Bioimplants Market by Country
    • 6.2.2.5 Europe Ophthalmology Bioimplants Market by Country
    • 6.2.2.6 Europe Others Market by Country
  • 6.2.3 Europe Bioimplants Market by Country
    • 6.2.3.1 Germany Bioimplants Market
      • 6.2.3.1.1 Germany Bioimplants Market by End User
      • 6.2.3.1.2 Germany Bioimplants Market by Type
    • 6.2.3.2 UK Bioimplants Market
      • 6.2.3.2.1 UK Bioimplants Market by End User
      • 6.2.3.2.2 UK Bioimplants Market by Type
    • 6.2.3.3 France Bioimplants Market
      • 6.2.3.3.1 France Bioimplants Market by End User
      • 6.2.3.3.2 France Bioimplants Market by Type
    • 6.2.3.4 Russia Bioimplants Market
      • 6.2.3.4.1 Russia Bioimplants Market by End User
      • 6.2.3.4.2 Russia Bioimplants Market by Type
    • 6.2.3.5 Spain Bioimplants Market
      • 6.2.3.5.1 Spain Bioimplants Market by End User
      • 6.2.3.5.2 Spain Bioimplants Market by Type
    • 6.2.3.6 Italy Bioimplants Market
      • 6.2.3.6.1 Italy Bioimplants Market by End User
      • 6.2.3.6.2 Italy Bioimplants Market by Type
    • 6.2.3.7 Rest of Europe Bioimplants Market
      • 6.2.3.7.1 Rest of Europe Bioimplants Market by End User
      • 6.2.3.7.2 Rest of Europe Bioimplants Market by Type
• 6.3 Asia Pacific Bioimplants Market
  • 6.3.1 Asia Pacific Bioimplants Market by End User
    • 6.3.1.1 Asia Pacific Hospitals Market by Country
    • 6.3.1.2 Asia Pacific Speciality Clinics Market by Country
    • 6.3.1.3 Asia Pacific Ambulatory Surgical Centers Market by Country
  • 6.3.2 Asia Pacific Bioimplants Market by Type
    • 6.3.2.1 Asia Pacific Orthopedic Bioimplants Market by Country
    • 6.3.2.2 Asia Pacific Cardiovascular Bioimplants Market by Country
    • 6.3.2.3 Asia Pacific Spinal Bioimplants Market by Country
    • 6.3.2.4 Asia Pacific Dental Bioimplants Market by Country
    • 6.3.2.5 Asia Pacific Ophthalmology Bioimplants Market by Country
    • 6.3.2.6 Asia Pacific Others Market by Country
  • 6.3.3 Asia Pacific Bioimplants Market by Country
    • 6.3.3.1 China Bioimplants Market
      • 6.3.3.1.1 China Bioimplants Market by End User
      • 6.3.3.1.2 China Bioimplants Market by Type
    • 6.3.3.2 Japan Bioimplants Market
      • 6.3.3.2.1 Japan Bioimplants Market by End User
      • 6.3.3.2.2 Japan Bioimplants Market by Type
    • 6.3.3.3 India Bioimplants Market
      • 6.3.3.3.1 India Bioimplants Market by End User
      • 6.3.3.3.2 India Bioimplants Market by Type
    • 6.3.3.4 South Korea Bioimplants Market
      • 6.3.3.4.1 South Korea Bioimplants Market by End User
      • 6.3.3.4.2 South Korea Bioimplants Market by Type
    • 6.3.3.5 Singapore Bioimplants Market
      • 6.3.3.5.1 Singapore Bioimplants Market by End User
      • 6.3.3.5.2 Singapore Bioimplants Market by Type
    • 6.3.3.6 Malaysia Bioimplants Market
      • 6.3.3.6.1 Malaysia Bioimplants Market by End User
      • 6.3.3.6.2 Malaysia Bioimplants Market by Type
    • 6.3.3.7 Rest of Asia Pacific Bioimplants Market
      • 6.3.3.7.1 Rest of Asia Pacific Bioimplants Market by End User
      • 6.3.3.7.2 Rest of Asia Pacific Bioimplants Market by Type
• 6.4 LAMEA Bioimplants Market
  • 6.4.1 LAMEA Bioimplants Market by End User
    • 6.4.1.1 LAMEA Hospitals Market by Country
    • 6.4.1.2 LAMEA Speciality Clinics Market by Country
    • 6.4.1.3 LAMEA Ambulatory Surgical Centers Market by Country
  • 6.4.2 LAMEA Bioimplants Market by Type
    • 6.4.2.1 LAMEA Orthopedic Bioimplants Market by Country
    • 6.4.2.2 LAMEA Cardiovascular Bioimplants Market by Country
    • 6.4.2.3 LAMEA Spinal Bioimplants Market by Country
    • 6.4.2.4 LAMEA Dental Bioimplants Market by Country
    • 6.4.2.5 LAMEA Ophthalmology Bioimplants Market by Country
    • 6.4.2.6 LAMEA Others Market by Country
  • 6.4.3 LAMEA Bioimplants Market by Country
    • 6.4.3.1 Brazil Bioimplants Market
      • 6.4.3.1.1 Brazil Bioimplants Market by End User
      • 6.4.3.1.2 Brazil Bioimplants Market by Type
    • 6.4.3.2 Argentina Bioimplants Market
      • 6.4.3.2.1 Argentina Bioimplants Market by End User
      • 6.4.3.2.2 Argentina Bioimplants Market by Type
    • 6.4.3.3 UAE Bioimplants Market
      • 6.4.3.3.1 UAE Bioimplants Market by End User
      • 6.4.3.3.2 UAE Bioimplants Market by Type
    • 6.4.3.4 Saudi Arabia Bioimplants Market
      • 6.4.3.4.1 Saudi Arabia Bioimplants Market by End User
      • 6.4.3.4.2 Saudi Arabia Bioimplants Market by Type
    • 6.4.3.5 South Africa Bioimplants Market
      • 6.4.3.5.1 South Africa Bioimplants Market by End User
      • 6.4.3.5.2 South Africa Bioimplants Market by Type
    • 6.4.3.6 Nigeria Bioimplants Market
      • 6.4.3.6.1 Nigeria Bioimplants Market by End User
      • 6.4.3.6.2 Nigeria Bioimplants Market by Type
    • 6.4.3.7 Rest of LAMEA Bioimplants Market
      • 6.4.3.7.1 Rest of LAMEA Bioimplants Market by End User
      • 6.4.3.7.2 Rest of LAMEA Bioimplants Market by Type

Chapter 7. Company Profiles

• 7.1 Stryker Corporation
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expenses
  • 7.1.5 SWOT Analysis
• 7.2 Arthrex, Inc.
  • 7.2.1 Company Overview
  • 7.2.2 SWOT Analysis
• 7.3 Zimmer Biomet Holdings, Inc.
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental and Regional Analysis
  • 7.3.4 Research & Development Expense
  • 7.3.5 SWOT Analysis
• 7.4 Medtronic PLC
  • 7.4.1 Company overview
  • 7.4.2 Financial Analysis
  • 7.4.3 Segmental and Regional Analysis
  • 7.4.4 Research & Development Expenses
  • 7.4.5 SWOT Analysis
• 7.5 Smith & Nephew PLC
  • 7.5.1 Company Overview
  • 7.5.2 Financial Analysis
  • 7.5.3 Regional and Segmental Analysis
  • 7.5.4 Research & Development Expense
  • 7.5.5 SWOT Analysis
• 7.6 Dentsply Sirona, Inc.
  • 7.6.1 Company Overview
  • 7.6.2 Financial Analysis
  • 7.6.3 Segmental and Regional Analysis
  • 7.6.4 Research & Development Expenses
  • 7.6.5 SWOT Analysis
• 7.7 Johnson & Johnson
  • 7.7.1 Company Overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Segmental & Regional Analysis
  • 7.7.4 Research & Development Expenses
  • 7.7.5 SWOT Analysis
• 7.8 Boston Scientific Corporation
  • 7.8.1 Company Overview
  • 7.8.2 Financial Analysis
  • 7.8.3 Segmental and Regional Analysis
  • 7.8.4 Research & Development Expense
  • 7.8.5 SWOT Analysis
• 7.9 Abbott Laboratories
  • 7.9.1 Company Overview
  • 7.9.2 Financial Analysis
  • 7.9.3 Segmental and Regional Analysis
  • 7.9.4 Research & Development Expense
  • 7.9.5 SWOT Analysis
• 7.10. Victrex plc
  • 7.10.1 Company Overview
  • 7.10.2 Financial Analysis
  • 7.10.3 Segmental and Regional Analysis
  • 7.10.4 Research & Development Expenses

Chapter 8. Winning Imperatives of Bioimplants Market

관련자료